87 related articles for article (PubMed ID: 2642435)
1. Intravenous glucose tolerance and pancreatic islet beta-cell function in patients with multiple sclerosis during 2-yr treatment with cyclosporin.
Robertson RP; Franklin G; Nelson L
Diabetes; 1989 Jan; 38(1):58-64. PubMed ID: 2642435
[TBL] [Abstract][Full Text] [Related]
2. Glucose homeostasis and insulin secretion during chronic treatment with cyclosporin in nondiabetic humans.
Robertson RP; Franklin G; Nelson L
Diabetes; 1989 Jan; 38 Suppl 1():99-100. PubMed ID: 2642866
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of cyclosporin A on cultured mouse pancreatic islets.
Andersson A; Borg H; Hallberg A; Hellerström C; Sandler S; Schnell A
Diabetologia; 1984 Jul; 27 Suppl():66-9. PubMed ID: 6383922
[TBL] [Abstract][Full Text] [Related]
4. The effects of cyclosporin A on glucose homeostasis and the kidney in the normal rat.
Whiting PH; Thomson KJ; Saunders NJ; Simpson JG
J Exp Pathol (Oxford); 1990 Apr; 71(2):245-55. PubMed ID: 2184872
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
Diabetes; 1988 Nov; 37(11):1574-82. PubMed ID: 2903105
[TBL] [Abstract][Full Text] [Related]
6. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
Li X; Zhou ZG; Qi HY; Chen XY; Huang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
[TBL] [Abstract][Full Text] [Related]
7. [Effects of severe hyperglycaemia in pregnancy and early overfeeding on islet development and insulin resistance].
Zeng CJ; Zhang L; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):658-63. PubMed ID: 21092544
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
Lohmann T; List C; Lamesch P; Kohlhaw K; Wenzke M; Schwarz C; Richter O; Hauss J; Seissler J
Exp Clin Endocrinol Diabetes; 2000; 108(5):347-52. PubMed ID: 10989953
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Jos J; Boitard C; Assan R; Robert JJ
Diabetes Care; 1995 Nov; 18(11):1487-90. PubMed ID: 8722075
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function.
Chen M; Bergman RN; Pacini G; Porte D
J Clin Endocrinol Metab; 1985 Jan; 60(1):13-20. PubMed ID: 3880560
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of purified islet cells in diabetic rats. III. Immunosuppressive effect of cyclosporin.
Pipeleers-Marichal M; Ling ZD; Teng H; Pipeleers DG
Diabetes; 1991 Jul; 40(7):931-8. PubMed ID: 2060729
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic islet transplantation in cynomolgus monkeys. Initial studies and evidence that cyclosporine impairs glucose tolerance in normal monkeys.
Stegall MD; Chabot J; Weber C; Reemtsma K; Hardy MA
Transplantation; 1989 Dec; 48(6):944-50. PubMed ID: 2512701
[TBL] [Abstract][Full Text] [Related]
13. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
[TBL] [Abstract][Full Text] [Related]
14. Reversibility of the acute toxic effect of cyclosporin A on pancreatic B cells of Wistar rats.
Hahn HJ; Dunger A; Laube F; Besch W; Radloff E; Kauert C; Kotzke G
Diabetologia; 1986 Aug; 29(8):489-94. PubMed ID: 2428691
[TBL] [Abstract][Full Text] [Related]
15. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
Berkowitz K; Peters R; Kjos SL; Goico J; Marroquin A; Dunn ME; Xiang A; Azen S; Buchanan TA
Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of dispersed pancreatic islet tissue in humans: autografts and allografts.
Sutherland DE; Matas AJ; Goetz FC; Najarian JS
Diabetes; 1980; 29 Suppl 1():31-44. PubMed ID: 6766413
[TBL] [Abstract][Full Text] [Related]
17. Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.
Dufrane D; Maillart JF; Aouassar N; Goebbels RM; Guiot Y; Gianello P
Xenotransplantation; 2009; 16(3):152-63. PubMed ID: 19566655
[TBL] [Abstract][Full Text] [Related]
18. Diminished insulin secretory reserve in diabetic pancreas transplant and nondiabetic kidney transplant recipients.
Teuscher AU; Seaquist ER; Robertson RP
Diabetes; 1994 Apr; 43(4):593-8. PubMed ID: 8138066
[TBL] [Abstract][Full Text] [Related]
19. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
[TBL] [Abstract][Full Text] [Related]
20. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.
Larsson H; Ahrén B
J Clin Endocrinol Metab; 1999 Jun; 84(6):2068-74. PubMed ID: 10372712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
